JP2024525742A5 - - Google Patents
Info
- Publication number
- JP2024525742A5 JP2024525742A5 JP2024501820A JP2024501820A JP2024525742A5 JP 2024525742 A5 JP2024525742 A5 JP 2024525742A5 JP 2024501820 A JP2024501820 A JP 2024501820A JP 2024501820 A JP2024501820 A JP 2024501820A JP 2024525742 A5 JP2024525742 A5 JP 2024525742A5
- Authority
- JP
- Japan
- Prior art keywords
- sequence
- expression construct
- vector
- construct according
- pharmaceutical composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163221879P | 2021-07-14 | 2021-07-14 | |
| US63/221,879 | 2021-07-14 | ||
| PCT/IB2022/056457 WO2023285986A1 (en) | 2021-07-14 | 2022-07-13 | Kcnv2 gene therapy |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024525742A JP2024525742A (ja) | 2024-07-12 |
| JP2024525742A5 true JP2024525742A5 (enExample) | 2025-07-22 |
Family
ID=82932641
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024501820A Pending JP2024525742A (ja) | 2021-07-14 | 2022-07-13 | Ｋｃｎｖ２遺伝子治療 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20240307559A1 (enExample) |
| EP (1) | EP4370538A1 (enExample) |
| JP (1) | JP2024525742A (enExample) |
| KR (1) | KR20240052746A (enExample) |
| CN (1) | CN118019757A (enExample) |
| AU (1) | AU2022311329B2 (enExample) |
| CA (1) | CA3225080A1 (enExample) |
| IL (1) | IL310018A (enExample) |
| MX (1) | MX2024000748A (enExample) |
| WO (1) | WO2023285986A1 (enExample) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2026150224A1 (en) | 2024-12-30 | 2026-07-16 | MeiraGTx Ocular UK Limited | Modified adeno-associated virus (aav) viral capsid proteins and methods of use |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE4345297A1 (de) | 1993-11-11 | 1995-09-28 | Nsm Ag | Geldspielgerät |
| US5856152A (en) | 1994-10-28 | 1999-01-05 | The Trustees Of The University Of Pennsylvania | Hybrid adenovirus-AAV vector and methods of use therefor |
| CA2346262A1 (en) | 1998-09-17 | 2000-03-23 | University Of Florida | Methods for treatment of degenerative retinal diseases |
| SMT202000715T1 (it) * | 2014-07-24 | 2021-01-05 | Massachusetts Eye & Ear Infirmary | Terapia genica rpgr per la retinite pigmentosa |
| MA44546B1 (fr) | 2016-06-15 | 2021-03-31 | Univ California | Virus adéno-associés variants et procédés d'utilisation |
| CA3071769A1 (en) * | 2017-07-31 | 2019-02-07 | Reflection Biotechnologies Limited | Cellular models of and therapies for ocular diseases |
| GB201800546D0 (en) * | 2018-01-12 | 2018-02-28 | Ucl Business Plc | Treatment |
| WO2022246089A1 (en) * | 2021-05-20 | 2022-11-24 | Artema Therapeutics, Inc. | Kcnv2 variants and their use |
-
2022
- 2022-07-13 CA CA3225080A patent/CA3225080A1/en active Pending
- 2022-07-13 US US18/578,623 patent/US20240307559A1/en active Pending
- 2022-07-13 CN CN202280061604.XA patent/CN118019757A/zh active Pending
- 2022-07-13 EP EP22754917.7A patent/EP4370538A1/en active Pending
- 2022-07-13 AU AU2022311329A patent/AU2022311329B2/en active Active
- 2022-07-13 JP JP2024501820A patent/JP2024525742A/ja active Pending
- 2022-07-13 KR KR1020247004694A patent/KR20240052746A/ko active Pending
- 2022-07-13 MX MX2024000748A patent/MX2024000748A/es unknown
- 2022-07-13 WO PCT/IB2022/056457 patent/WO2023285986A1/en not_active Ceased
- 2022-07-13 IL IL310018A patent/IL310018A/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US20220331409A1 (en) | Factor ix gene therapy | |
| CN104937100B (zh) | Aav 变体 | |
| US8574583B2 (en) | AAV capsid library and AAV capsid proteins | |
| CN117157309A (zh) | 衣壳变异的重组腺相关病毒及其应用 | |
| JP2018515096A (ja) | 神経成長因子シグナルペプチド及び副甲状腺ホルモンを含むａａｖ分離株及び融合タンパク質 | |
| JP2020528734A5 (enExample) | ||
| JP2020510428A5 (enExample) | ||
| RU2018125468A (ru) | Генная терапия офтальмологических нарушений | |
| RU2020137429A (ru) | Лечение пигментного ретинита | |
| JP2025515979A5 (enExample) | ||
| JP2022529782A5 (enExample) | ||
| US20240191254A1 (en) | Transgene cassettes designed to express a human mecp2 gene | |
| JP2022522776A5 (enExample) | ||
| JP2017529395A5 (enExample) | ||
| CN115151647A (zh) | Dna扩增方法 | |
| CN111876432A (zh) | 一组肝靶向新型腺相关病毒的获得及其应用 | |
| US11077208B2 (en) | Wilson's disease gene therapy | |
| JP2022533448A5 (enExample) | ||
| JP2018526994A5 (enExample) | ||
| JP2024527742A5 (enExample) | ||
| JP2023542241A5 (enExample) | ||
| JP2020510433A5 (enExample) | ||
| Chen | Adeno-associated virus vectors for human gene therapy | |
| JP2022552892A5 (enExample) | ||
| JP2024525721A5 (enExample) |